1.42
+0(+0.00%)
Currency In USD
Address
2080 Century Park East
Los Angeles, CA 90067
United States of America
Phone
305 918 1980
Website
Sector
Healthcare
Industry
Biotechnology
Employees
25
First IPO Date
February 07, 2018
| Name | Title | Pay | Year Born |
| Mr. David H. Weinstein | Chief Executive Officer & Director | 0 | 1961 |
| Mr. Greg Duczynski Ph.D. | Senior Vice President for Clinical Operations | 0 | N/A |
| Mr. Nathen Fuentes CPA | Chief Financial Officer | 0 | 1983 |
Lunai Bioworks, Inc. is a pre-clinical stage biotechnology company, which engages in the development of genetically modified cellular and immune-therapy technologies used for the treatment of infectious diseases and cancer. Its pipeline consists of ENOB-HV-01, ENOB- HV-11, ENOB-HV-12, ENOB-DB-01, ENOB-DC-01, ENOB-DC-11, and ENOB-DC-21. The company was founded by Rene Sindlev and Serhat Gumrukcu on January 18, 2011 and is headquartered in Los Angeles, CA.